کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1946595 | 1054256 | 2012 | 10 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Targeting epigenetic mediators of gene expression in thoracic malignancies Targeting epigenetic mediators of gene expression in thoracic malignancies](/preview/png/1946595.png)
Lung and esophageal cancers and malignant pleural mesotheliomas are highly lethal neoplasms that are leading causes of cancer-related deaths worldwide. Presently, limited information is available pertaining to epigenetic mechanisms mediating initiation and progression of these neoplasms. The following presentation will focus on the potential clinical relevance of epigenomic alterations in thoracic malignancies mediated by DNA methylation, perturbations in the histone code, and polycomb group proteins, as well as ongoing translational efforts to target epigenetic regulators of gene expression for treatment of these neoplasms. This article is part of a Special Issue entitled: Chromatin in time and space.
► Overview of clinically relevant alterations in DNA methylation in thoracic malignancies.
► Correlation of histone alterations and polycomb protein expression with patient outcome.
► Review of translational efforts to target the epigenome in thoracic malignancies.
Journal: Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms - Volume 1819, Issue 7, July 2012, Pages 836–845